NO994931L - Chelateringsmidler - Google Patents

Chelateringsmidler

Info

Publication number
NO994931L
NO994931L NO994931A NO994931A NO994931L NO 994931 L NO994931 L NO 994931L NO 994931 A NO994931 A NO 994931A NO 994931 A NO994931 A NO 994931A NO 994931 L NO994931 L NO 994931L
Authority
NO
Norway
Prior art keywords
different
group
same
optionally substituted
hydrogen
Prior art date
Application number
NO994931A
Other languages
English (en)
Norwegian (no)
Other versions
NO994931D0 (no
Inventor
Shi-Bao Yu
Jasbir Singh
Louise Golding
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO994931D0 publication Critical patent/NO994931D0/no
Publication of NO994931L publication Critical patent/NO994931L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
NO994931A 1997-04-11 1999-10-08 Chelateringsmidler NO994931L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/833,995 US6004529A (en) 1997-04-11 1997-04-11 Chelating agents
PCT/GB1998/001078 WO1998046276A1 (en) 1997-04-11 1998-04-14 Chelating agents

Publications (2)

Publication Number Publication Date
NO994931D0 NO994931D0 (no) 1999-10-08
NO994931L true NO994931L (no) 1999-12-08

Family

ID=25265829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994931A NO994931L (no) 1997-04-11 1999-10-08 Chelateringsmidler

Country Status (12)

Country Link
US (2) US6004529A (de)
EP (1) EP0973554B1 (de)
JP (1) JP2001521515A (de)
KR (1) KR20010006210A (de)
AT (1) ATE298254T1 (de)
AU (1) AU740759B2 (de)
BR (1) BR9808672A (de)
CA (1) CA2286790A1 (de)
DE (1) DE69830653T2 (de)
IL (1) IL132225A0 (de)
NO (1) NO994931L (de)
WO (1) WO1998046276A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004529A (en) 1997-04-11 1999-12-21 Nycomed Imaging As Chelating agents
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
US6248222B1 (en) * 1998-09-08 2001-06-19 Acm Research, Inc. Methods and apparatus for holding and positioning semiconductor workpieces during electropolishing and/or electroplating of the workpieces
US6623655B1 (en) 2000-04-24 2003-09-23 Sigma-Aldrich Co. Metal chelating compositions
US6928315B1 (en) 2000-05-21 2005-08-09 Mirabel Medical Systems Ltd. Apparatus for impedance imaging coupled with another modality
CN115028561B (zh) * 2022-06-16 2023-12-22 江西省科学院应用化学研究所 硫代二甘酰胺酸类萃取剂及其制备方法和应用
CN117466929A (zh) * 2022-07-21 2024-01-30 成都圣诺生物制药有限公司 一种新的半胱氨酸衍生物及其在制备环肽中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU672951B2 (en) * 1992-05-07 1996-10-24 Ge Healthcare As Complexing agents and targeting immunoreagents
AU5019193A (en) * 1992-08-19 1994-03-15 Mallinckrodt Medical, Inc. Ligands for ga-68 pet heart applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5443953A (en) * 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US6004529A (en) 1997-04-11 1999-12-21 Nycomed Imaging As Chelating agents

Also Published As

Publication number Publication date
AU740759B2 (en) 2001-11-15
ATE298254T1 (de) 2005-07-15
WO1998046276A1 (en) 1998-10-22
US6004529A (en) 1999-12-21
IL132225A0 (en) 2001-03-19
DE69830653T2 (de) 2006-05-04
US6280706B1 (en) 2001-08-28
BR9808672A (pt) 2000-07-11
WO1998046276A8 (en) 1999-07-22
EP0973554B1 (de) 2005-06-22
JP2001521515A (ja) 2001-11-06
AU7059798A (en) 1998-11-11
DE69830653D1 (en) 2005-07-28
EP0973554A1 (de) 2000-01-26
KR20010006210A (ko) 2001-01-26
NO994931D0 (no) 1999-10-08
CA2286790A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
IL108731A (en) 6, N-DISUBSTITUTED-£1, 2, 4| TRIAZOLO-£1, 5-a| PYRIMIDINE- 7-AMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS FUNGICIDES
TW370450B (en) Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
PA8538201A1 (es) Inhibidores de piridina de metaloproteinasas de la matriz
DE59308619D1 (de) Germicide wirkstoffkombinationen
AR006390A1 (es) Derivados de lactama
NO953305L (no) Antranilsyrederivat
NO20052469L (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
ES2105920B1 (es) Procedimiento para preparar compuestos de benzo-y piridopiridazinona y piridazinationa.
TW351668B (en) Oxymethoxy-3-aryl-pyrone derivatives, their preparation, their use for controlling pest and pesticides containing the same
NO994931L (no) Chelateringsmidler
EP0655448A4 (de)
DE69925472D1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
ES2120037T3 (es) 1-fenil- o 1-piridinil-benzotriazoles substituidos herbicidas.
FI903936A0 (fi) Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl.
YU248190A (sh) Fungicidi
DE69910568D1 (de) Furopyridinderivate und ihre therapeutische verwendung
TR199901205T2 (xx) Farnesil protein transferaz inhibasyonu i�in kullan�lan de�i�tirilmi� benzosikloheptapiridin t�revleri
DE69416683D1 (de) Benzolactam-derivate
PE33796A1 (es) Compuesto ariltio
DK0787710T3 (da) Fluorpropenforbindelse, et insekticid indeholdende samme og et mellemprodukt til fremstilling deraf
KR970003950B1 (en) Wholly aromatic polyester and method for manufacturing the same
DE502004009016D1 (de) Verwendung von chinaldin-und naphthalinderivaten als kristallisationsmodifikatoren
ID29395A (id) Zat warna diazo yang reaktif terhadap serat
BR9508979A (pt) Carboxamidas bicíclicas como antagonistas de 5-ht1a
EP0055442A3 (en) N-sulfenylated biurets, process for their preparation, and their use as fungicides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application